183 related articles for article (PubMed ID: 37598220)
1. Epigenetic and molecular coordination between HDAC2 and SMAD3-SKI regulates essential brain tumour stem cell characteristics.
Bahia RK; Hao X; Hassam R; Cseh O; Bozek DA; Luchman HA; Weiss S
Nat Commun; 2023 Aug; 14(1):5051. PubMed ID: 37598220
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cells.
Was H; Krol SK; Rotili D; Mai A; Wojtas B; Kaminska B; Maleszewska M
Clin Epigenetics; 2019 Jan; 11(1):11. PubMed ID: 30654849
[TBL] [Abstract][Full Text] [Related]
3. Transforming pathways unleashed by a HDAC2 mutation in human cancer.
Ropero S; Ballestar E; Alaminos M; Arango D; Schwartz S; Esteller M
Oncogene; 2008 Jun; 27(28):4008-12. PubMed ID: 18264134
[TBL] [Abstract][Full Text] [Related]
4. Differences among brain tumor stem cell types and fetal neural stem cells in focal regions of histone modifications and DNA methylation, broad regions of modifications, and bivalent promoters.
Yoo S; Bieda MC
BMC Genomics; 2014 Aug; 15(1):724. PubMed ID: 25163646
[TBL] [Abstract][Full Text] [Related]
5. miR-3189-targeted GLUT3 repression by HDAC2 knockdown inhibits glioblastoma tumorigenesis through regulating glucose metabolism and proliferation.
Kwak S; Park SH; Kim SH; Sung GJ; Song JH; Jeong JH; Kim H; Ha CH; Kim SW; Choi KC
J Exp Clin Cancer Res; 2022 Mar; 41(1):87. PubMed ID: 35260183
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-223 controls the expression of histone deacetylase 2: a novel axis in COPD.
Leuenberger C; Schuoler C; Bye H; Mignan C; Rechsteiner T; Hillinger S; Opitz I; Marsland B; Faiz A; Hiemstra PS; Timens W; Camici GG; Kohler M; Huber LC; Brock M
J Mol Med (Berl); 2016 Jun; 94(6):725-34. PubMed ID: 26864305
[TBL] [Abstract][Full Text] [Related]
7. Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL.
Stubbs MC; Kim W; Bariteau M; Davis T; Vempati S; Minehart J; Witkin M; Qi J; Krivtsov AV; Bradner JE; Kung AL; Armstrong SA
Clin Cancer Res; 2015 May; 21(10):2348-58. PubMed ID: 25688158
[TBL] [Abstract][Full Text] [Related]
8. An essential role for Mad homology domain 1 in the association of Smad3 with histone deacetylase activity*.
Liberati NT; Moniwa M; Borton AJ; Davie JR; Wang XF
J Biol Chem; 2001 Jun; 276(25):22595-603. PubMed ID: 11306568
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts.
Cho JS; Moon YM; Park IH; Um JY; Moon JH; Park SJ; Lee SH; Kang HJ; Lee HM
Clin Exp Allergy; 2012 Jun; 42(6):872-82. PubMed ID: 22239687
[TBL] [Abstract][Full Text] [Related]
10. On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells.
Stechishin OD; Luchman HA; Ruan Y; Blough MD; Nguyen SA; Kelly JJ; Cairncross JG; Weiss S
Neuro Oncol; 2013 Feb; 15(2):198-207. PubMed ID: 23262510
[TBL] [Abstract][Full Text] [Related]
11. Neuronal susceptibility to beta-amyloid toxicity and ischemic injury involves histone deacetylase-2 regulation of endophilin-B1.
Wang DB; Kinoshita C; Kinoshita Y; Sopher BL; Uo T; Lee RJ; Kim JK; Murphy SP; Dirk Keene C; Garden GA; Morrison RS
Brain Pathol; 2019 Mar; 29(2):164-175. PubMed ID: 30028551
[TBL] [Abstract][Full Text] [Related]
12. A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition.
Ropero S; Fraga MF; Ballestar E; Hamelin R; Yamamoto H; Boix-Chornet M; Caballero R; Alaminos M; Setien F; Paz MF; Herranz M; Palacios J; Arango D; Orntoft TF; Aaltonen LA; Schwartz S; Esteller M
Nat Genet; 2006 May; 38(5):566-9. PubMed ID: 16642021
[TBL] [Abstract][Full Text] [Related]
13. Sin3a-associated Hdac1 and Hdac2 are essential for hematopoietic stem cell homeostasis and contribute differentially to hematopoiesis.
Heideman MR; Lancini C; Proost N; Yanover E; Jacobs H; Dannenberg JH
Haematologica; 2014 Aug; 99(8):1292-303. PubMed ID: 24763403
[TBL] [Abstract][Full Text] [Related]
14. Silencing histone deacetylase 2 using small hairpin RNA induces regression of fibrotic plaque in a rat model of Peyronie's disease.
Kwon KD; Choi MJ; Park JM; Song KM; Kwon MH; Batbold D; Yin GN; Kim WJ; Ryu JK; Suh JK
BJU Int; 2014 Dec; 114(6):926-36. PubMed ID: 24841412
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic disruption of histone deacetylase-2 accelerated apoptotic signaling and retarded malignancy in gastric cells.
Hosseini SA; Ghatrehsamani M; Yaghoobi H; Elahian F; Mirzaei SA
Epigenomics; 2024 Mar; 16(5):277-292. PubMed ID: 38356395
[TBL] [Abstract][Full Text] [Related]
16. Loss of epigenetic Kruppel-like factor 4 histone deacetylase (KLF-4-HDAC)-mediated transcriptional suppression is crucial in increasing vascular endothelial growth factor (VEGF) expression in breast cancer.
Ray A; Alalem M; Ray BK
J Biol Chem; 2013 Sep; 288(38):27232-27242. PubMed ID: 23926105
[TBL] [Abstract][Full Text] [Related]
17. Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion.
Restall I; Bozek DA; Chesnelong C; Weiss S; Luchman HA
J Vis Exp; 2018 Aug; (138):. PubMed ID: 30222149
[TBL] [Abstract][Full Text] [Related]
18. An inactivating mutation in HDAC2 leads to dysregulation of apoptosis mediated by APAF1.
Hanigan CL; Van Engeland M; De Bruine AP; Wouters KA; Weijenberg MP; Eshleman JR; Herman JG
Gastroenterology; 2008 Nov; 135(5):1654-1664.e2. PubMed ID: 18834886
[TBL] [Abstract][Full Text] [Related]
19. Ski inhibits TGF-β/phospho-Smad3 signaling and accelerates hypertrophic differentiation in chondrocytes.
Kim KO; Sampson ER; Maynard RD; O'Keefe RJ; Chen D; Drissi H; Rosier RN; Hilton MJ; Zuscik MJ
J Cell Biochem; 2012 Jun; 113(6):2156-66. PubMed ID: 22461172
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylases 1 and 2 are expressed at distinct stages of neuro-glial development.
MacDonald JL; Roskams AJ
Dev Dyn; 2008 Aug; 237(8):2256-67. PubMed ID: 18651664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
